<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-153816</identifier>
<setSpec>1130-0558</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Are bisphosphonates and dental implants compatible? A review of the literature</dc:title>
<dc:description xml:lang="en">Introduction. At present, treatment with bisphosphonates and dental implant therapy are frequently used in adults. Bisphosphonate-related osteonecrosis of the jaws has been described in patients with bisphosphonate medication who underwent dentoalveolar surgery. Objectives. The aim of this study was to evaluate, through a literature review, whether osseointegration of dental implants could decrease in patients on intravenous or oral bisphosphonates. The risk of developing bisphosphonate-related osteonecrosis of the jaws in these patients was also analysed. Material and methods. A search was performed to find the most recent scientific literature (the last 15 years) using PubMed database, with the keywords «bisphosphonates and dental implants», «bisphosphonates and orthopaedic implants» and «osteonecrosis of the jaws and dental implants». Conclusions. Based on the current literature, it is concluded that bisphosphonate treatment does not decrease osseointegration of dental implants. Nevertheless, these results have been obtained in a retrospective in humans. Bisphosphonate-related osteonecrosis of the jaws has been described in patients on prolonged treatment (AU)</dc:description>
<dc:creator>Moreno-Sánchez, Manuel</dc:creator>
<dc:creator>Monje Gil, Florencio</dc:creator>
<dc:creator>González-García, Raúl</dc:creator>
<dc:creator>Manzano Solo de Zaldívar, Damián</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. La osteonecrosis de los maxilares ha sido descrita en pacientes que toman bifosfonatos y han sido sometidos a cirugía dentoalveolar. Actualmente, la terapia con bifosfonatos e implantes dentales es un tratamiento muy común en adultos. Objetivos. Evaluar, a través de una revisión de la literatura, si la osteointegración del implante dental podría disminuir en pacientes que toman bifosfonatos orales o intravenosos. Además, se analiza el riesgo que tienen estos pacientes de desarrollar osteonecrosis de los maxilares. Material y métodos. Se realizó una búsqueda a través de la base de datos Medline (PubMed) de los artículos publicados en inglés en los últimos 15 años que incluyeran las palabras clave «bisphosphonates and dental implants», «bisphosphonates and orthopaedic implants» y «osteonecrosis of the jaws and dental implants». Conclusiones. El tratamiento con bifosfonatos no disminuye la osteointegración del implante dental, aunque estos resultados se han obtenido en base a estudios retrospectivos en humanos. Se han descrito casos de osteonecrosis de los maxilares relacionada con bifosfonatos en estos pacientes, sobre todo tras tratamiento prolongado (AU)</dc:description>
<dc:source>Rev. esp. cir. oral maxilofac;38(3): 128-135, jul.-sept. 2016. tab, ilus</dc:source>
<dc:identifier>ibc-153816</dc:identifier>
<dc:title xml:lang="es">Bifosfonatos e implantes dentales, ¿son incompatibles? Revisión de la literatura</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d10161^s22066</dc:subject>
<dc:subject>^d10161^s22074</dc:subject>
<dc:subject>^d8521^s22045</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d10200^s22053</dc:subject>
<dc:subject>^d10200^s22012</dc:subject>
<dc:subject>^d29076^s22021</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d54489^s22016</dc:subject>
<dc:subject>^d3771^s22074</dc:subject>
<dc:subject>^d54489^s22067</dc:subject>
<dc:subject>^d10200^s22036</dc:subject>
<dc:subject>^d4220^s22073</dc:subject>
<dc:subject>^d4220^s22044</dc:subject>
<dc:subject>^d3771^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>201609</dc:date>
</metadata>
</record>
</ibecs-document>
